检索结果(检索关键词为:GROWTH;结果共27条)
  • Yu, Chengtao; Tian, Fang; Liu, Jun; Su, Minhui; Wu, Min; Zhu, Xuejun; Qian, Wang
    CELL PROLIFERATION 2019年第52卷第3期 DOI:10.1111/cpr.12610
    关键词: NONCODING RNAS; CANCER; METASTASIS; MICRORNAS; GROWTH
    摘要: Objectives Circular RNA, a type of RNA formed by a covalently closed loop, possesses sophisticated abilities of gene regulation in tumorigenesis and metastasis. However, the role of circRNAs on lung adenocarcinoma (LUAD) remains largely unknown. Materials and methods The role of cMras was examined both in vitro and in vivo. cMras expression in LUAD tissues was determined by quantitative real-time PCR (qRT-PCR). Downstream targets of cMras were predicted by bioinformatics tools and confirmed by RNA immunoprecipitation assay and luciferase assay. qRT-PCR and western blot assay were used to detect the expression of specific targets. Results Thirty-six paired LUAD and healthy tissues were collected and cMras resulted significantly downregulated in cancerous tissues. Its expression was negatively associated with tumour stages. cMras overexpression suppressed LUAD growth and metastasis, while endogenous cMras silencing resulted in the opposite effects. Bioinformatics analysis and experimental evidence confirmed that cMras was a sponge of miRNA-567 and released its direct target, PTPRG. cMras overexpression decreased miR-567 expression and subsequently increased PTPRG expression, while increased miRNA-567 expression blocked the effects induced by cMras. Moreover, PTPRG was downregulated in LUAD and patients with low PTPRG expression exhibited significantly poor prognosis. These results suggested that cMras/miR-567/PTPRG regulatory pathway might be associated to LUAD tumorigenesis and development. Conclusions A novel circular RNA cMras and its functions were identified, discovering a cMras/miR-567/PTPRG regulatory pathway in LUAD tumorigenesis and development.

  • Sun, Qian; Dong, Huimin; Li, Yuntao; Yuan, Fan'en; Xu, Yang; Mao, Shanping; Xiong, Xiaoxing; Chen, Qianxue; Liu, Baohui
    CELL PROLIFERATION 2019年第52卷第5期 DOI:10.1111/cpr.12665
    关键词: ROCK-I; ACTIVATION; EXPRESSION; RND3; PROLIFERATION; ORGANIZATION; PROMOTES; GROWTH; BINDS
    摘要: Objectives Abnormal activation of NF-kappa B signalling is a major mechanism of apoptosis resistance in glioblastoma multiforme (GBM). Therefore, better understanding of the regulation of NF-kappa B signalling has a significant impact for GBM therapy. Here, we uncovered a critical role of the small GTPase RND3 in regulating the p65 subunit of NF-kappa B and NF-kappa B signalling in GBM. Materials and methods Human GBM samples, GBM cells and a human orthotopic GBM-xenografted animal model were used. The mechanisms of RND3 in regulation of NF-kappa B signalling and GBM cell apoptosis were examined by luciferase assay, quantitative PCR, immunostaining, immunoblotting, immunofluorescence, coimmunoprecipitation, TUNEL staining, JC-1 analysis and flow cytometry. Results Overexpression of RND3 led to reduced p65 activity in GBM-cultured cells and a GBM animal model, indicating that the NF-kappa B pathway is negatively regulated by RND3 in GBM. Mechanistically, we found that RND3 bound p65 and promoted p65 ubiquitination, leading to decreased p65 protein levels. Furthermore, RND3 enhanced cleaved caspase 3 levels and promoted apoptosis in GBM cells, and RND3 expression was positively correlated with cleaved caspase 3 and IL-8 in human GBM samples. The effect of RND3 on promoting apoptosis disappeared when p65 ubiquitination was blocked by protease inhibitor carfilzomib or upon co-expression of ectopic p65. Conclusions RND3 binds p65 protein and promotes its ubiquitination, resulting in reduced p65 protein expression and inhibition of NF-kappa B signalling to induce GBM cell apoptosis.

  • Wang, Qingxuan; Zhou, Chenchen; Li, Xiaobing; Cai, Linyi; Zou, Jing; Zhang, Demao; Xie, Jing; Lai, Wenli
    CELL PROLIFERATION 2019年第52卷第2期 DOI:10.1111/cpr.12544
    关键词: REGULATES CONNEXIN43 EXPRESSION; BETA TGF-BETA; ARTICULAR CHONDROCYTES; GROWTH; HEMICHANNELS; OSTEOARTHRITIS; COMMUNICATION; MECHANISM
    摘要: Objectives Connexin-mediated functional gap junction intercellular communication (GJIC) has a vital role in development, homeostasis and pathology. Transforming growth factor-beta 1 (TGF-beta 1), as one of the most vital factors in chondrocytes, promotes cartilage precursor cell differentiation and chondrocyte proliferation, migration and metabolism. However, how TGF-beta 1 mediates GJIC in chondrocytes remains unclear. This study aims to determine the influence of TGF-beta 1 on GJIC in mouse chondrocytes and its underlying mechanism. Methods qPCR and mRNA microarray were used to verify the expression of genes in the TGF-beta and connexin families in cartilage and chondrocytes. A scrape loading/dye transfer assay was performed to explore GJIC. Western blot analysis was used to detect connexin43 (Cx43) and Smad signalling components. Immunofluorescence staining was performed to characterize protein distribution. Results The TGF-beta 1 mRNA was the highest expressed member of the TGF beta super family in cartilage. TGF-beta 1 promoted functional GJIC through increased expression of Cx43. TGF-beta 1-mediated GJIC required the participation of TGF-beta type I receptor. TGF-beta 1 activated Smad3 and Smad4 signalling to facilitate their nuclear translocation. The Smad3 and Smad4 signalling proteins bound to the promoter of Gja1 and thus initiated Cx43 gene expression. Conclusions For the first time, these results revealed a vital role of TGF-beta 1 in cell-cell communication in chondrocytes via gap junction formation. We describe the regulatory mechanism, the involvement of TGF-beta type I receptor and the nuclear translocation of Smad3/4.

  • Li, Yue; Zhao, Yu; Wang, Yan
    CELL PROLIFERATION 2019年第52卷第6期 DOI:10.1111/cpr.12707
    关键词: 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ALDOSE REDUCTASE; CATARACT; EMT; FIBROSIS; TRANSDIFFERENTIATION; MELATONIN; GROWTH; MODEL
    摘要: Objectives Fibrosis is a complex process involved in multiple diseases that result in organ injury and failure. Cataract, one common form of ocular fibrosis, is a main cause of blindness worldwide, and surgery may be the only cure. In this regard, epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) is the primary cause of anterior subcapsular cataract (ASC). This study aimed to investigate the mechanism by which 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase) regulates the function of EMT in LECs. Materials and Methods A mouse model of ASC was used to observe the expression of CNPase in the lens and correlate its expression changes with lens EMT. Furthermore, the effects of CNPase on cell migration and cell proliferation were evaluated by transwell migration, wound healing and EdU staining assays. Finally, Western blotting and immunofluorescence were used to assess the mechanical properties potentially involved in the regulation of EMT by CNPase. Results The expression of CNPase was upregulated in LECs during the EMT process in mice with ASC. Notably, CNPase significantly promoted the proliferation, migration and EMT of LECs in vitro. Interestingly, the EMT-promoting mechanism of CNPase may be achieved by targeting the Notch signalling pathway. Conclusions Considering the involvement of EMT in ASC, both CNPase and the Notch signalling pathway may be therapeutic targets for the treatment of cataracts.

  • Chen, Zhiqiang; Zuo, Xueliang; Pu, Liyong; Zhang, Yao; Han, Guoyong; Zhang, Long; Wu, Zhengshan; You, Wei; Qin, Jianjie; Dai, Xinzheng; Shen, Hongbing; Wang, Xuehao; Wu, Jindao
    CELL PROLIFERATION 2019年第52卷第3期 DOI:10.1111/cpr.12581
    关键词: HIGH EXPRESSION; CANCER; METASTASIS; SUPPRESSES; PRESENILIN; PATHWAYS; CLEAVAGE; TARGET; GROWTH; GENE
    摘要: Objectives Kita-Kyushu lung cancer antigen-1 (KK-LC-1) is a cancer/testis antigen reactivated in several human malignancies. So far, the major focus of studies on KK-LC-1 has been on its potential as diagnostic biomarker and immunotherapy target. However, its biological functions and molecular mechanisms in cancer progression remain unknown. Materials and Methods Expression of KK-LC-1 in HCC was analysed using RT-qPCR, Western blot and immunohistochemistry. The roles of KK-LC-1 on HCC progression were examined by loss-of-function and gain-of-function approaches. Pathway inhibitor DAPT was employed to confirm the regulatory effect of KK-LC-1 on the downstream Notch signalling. The interaction of KK-LC-1 with presenilin-1 was determined by co-immunoprecipitation. The association of CpG island methylation status with KK-LC-1 reactivation was evaluated by methylation-specific PCR, bisulphite sequencing PCR and 5-Aza-dC treatment. Results We identified that HCC tissues exhibited increased levels of KK-LC-1. High KK-LC-1 level independently predicted poor survival outcome. KK-LC-1 promoted cell growth, migration, invasion and epithelial-mesenchymal transition in vitro and in vivo. KK-LC-1 modulated the Notch1/Hes1 pathway to exacerbate HCC progression through physically interacting with presenilin-1. Upregulation of KK-LC-1 in HCC was attributed to hypomethylated CpG islands. Conclusions This study identified that hypomethylation-induced KK-LC-1 overexpression played an important role in HCC progression and independently predicted poor survival. We defined the KK-LC-1/presenilin-1/Notch1/Hes1 as a novel signalling pathway that was involved in the growth and metastasis of HCC.